Foundayo: Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill
Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it…
Novo defends economics of Wegovy pill as lower prices weigh on sales; stock falls
Novo Nordisk‘s CEO sought to reassure investors that its Wegovy pill can drive profitable growth despite lower prices,…
Novo Nordisk stock falls as raised outlook fails to change the debate over obesity business
Novo Nordisk’s quarterly beat and guidance increase did little to resolve Wall Street’s biggest concern: whether the Ozempic…
Novo Nordisk (NVO) Q1 2026 earnings: Wegovy sales jump
People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in…
Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White…